SEC Filing Summary: Landec Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation (not Lifecore Biomedical, Inc.) on May 24, 2019, reporting events occurring on May 23, 2019. The registrant is incorporated in Delaware and trades on the NASDAQ Global Select Market under the symbol LNDC.
Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
The Board of Directors adopted an amendment to Section 2.5(a) of the Company's By-Laws. This amendment extends the deadline for submitting nominations for the Board of Directors and business proposals for the 2019 Annual Meeting of Stockholders to 5:00 p.m. PT on July 31, 2019.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly procedural regarding the By-Law amendment.
Key Facts for Investor Verification
- Verify the new deadline for shareholder proposals and director nominations is July 31, 2019, at 5:00 p.m. PT.
- Confirm the registrant is Landec Corporation (LNDC), as the input metadata incorrectly referenced Lifecore Biomedical, Inc.
- Note that this filing does not impact financial performance or provide earnings data.